Simon Amy's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Jul 3, 2025
- Accession no.
- 0000950170-25-094002
- Filed
- Jul 3, 2025
- Trade date
- Jul 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $24.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simon AmyCIK 0001963879 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | SSaleDisposed | −374 | $16.94 | −$6,335.56 | 65,740 | Direct | |
| Jul 3, 2025 | Common Stock | SSaleDisposed | −876 | $20.12 | −$17,625.12 | 64,864 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.